Holen Sie sich die Stockscreener-App
71.90
2.19%
-1.61
Handel nachbörslich:
71.90
Finanzdaten der Apogee Therapeutics Inc-Aktie (APGE)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
9.51%
78.06
|
71.28 | 73.17 | 63.10 | 58.69 |
| Operating Income/Loss |
9.51%
-78.06
|
-71.28 | -73.17 | -63.10 | -58.69 |
| Income/Loss From Continuing Operations Before Tax |
6.72%
-69.33
|
-64.96 | -66.02 | -55.26 | -49.02 |
| Income Tax Expense/Benefit |
1.64%
0.062
|
0.061 | 0.072 | 0.083 | - |
| Income/Loss From Continuing Operations After Tax |
6.71%
-69.39
|
-65.02 | -66.10 | -55.34 | -49.02 |
|
Net Income/Loss
|
6.71%
-69.39
|
-65.02 | -66.10 | -55.34 | -49.02 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
96.22%
2.2229
|
58.77 | 58.43 | 58.20 | 56.80 |
| Diluted Average Shares |
96.22%
2.2229
|
58.77 | 58.43 | 58.20 | 56.80 |
| Basic Earnings Per Share |
7.21%
-1.03
|
-1.11 | -1.13 | -0.95 | -0.86 |
| Diluted Earnings Per Share |
7.21%
-1.03
|
-1.11 | -1.13 | -0.95 | -0.86 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.48%
1.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):